Nitrofurantoin Macrocrystals Dosing for Uncomplicated UTI

Standard Dosing Regimen

The Infectious Diseases Society of America (IDSA) and the European Society for Microbiology and Infectious Diseases (ESMID) recommend a dose of 100 mg orally twice daily for 5 days for uncomplicated urinary tract infections in women 1, 2
A 5-day regimen of nitrofurantoin achieves clinical cure rates of 84-90% and bacterial cure rates of 92% at early follow-up (5-9 days post-treatment) in patients with uncomplicated UTI 2
At 30-day follow-up, clinical cure rates remain robust at 84%, demonstrating sustained efficacy in patients with uncomplicated UTI 2

A 7-day course (100 mg twice daily) is acceptable for uncomplicated UTI, with clinical cure rates of 89-93% and bacterial cure rates of 86%, as recommended by the IDSA 2
The 7-day regimen shows equivalent efficacy to ciprofloxacin and trimethoprim-sulfamethoxazole when comparing similar duration courses for uncomplicated UTI 2
The IDSA recommends avoiding 3-day regimens (100 mg four times daily) due to lower efficacy, with only 88% clinical cure and 74% bacterial cure rates for uncomplicated UTI 2

For vancomycin-resistant Enterococcus (VRE) UTIs, the recommended dose is 100 mg four times daily, as suggested by the Praxis Medical Insights 1
For children ≥12 years, the adult dose of 100 mg twice daily is appropriate for uncomplicated UTI, according to the Praxis Medical Insights 1
For children <12 years, the recommended dose is 5-7 mg/kg/day divided into 4 doses (maximum 100 mg/dose) for 7 days for uncomplicated UTI, as recommended by the Praxis Medical Insights 1

The IDSA recommends not using nitrofurantoin if creatinine clearance is <60 mL/min, as inadequate urinary drug concentrations prevent bactericidal activity and increase toxicity risk 1, 3
Nitrofurantoin is contraindicated if early pyelonephritis is suspected, as it does not achieve adequate tissue concentrations for upper tract infections, according to the Praxis Medical Insights 1

Nausea and headache are the most common adverse effects, occurring in 5.6-34% of patients depending on the study, with rates comparable to trimethoprim-sulfamethoxazole (31-38% adverse events) 1, 2

If local E. coli resistance to trimethoprim-sulfamethoxazole is <20% and the patient has no sulfa allergy, trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days is an equivalent alternative for uncomplicated UTI, as recommended by the IDSA and Praxis Medical Insights 1, 2
If the patient has impaired renal function (CrCl <60 mL/min), the IDSA recommends switching to trimethoprim-sulfamethoxazole or fosfomycin instead for uncomplicated UTI 1, 3
Fosfomycin 3 g single dose is an alternative first-line option with slightly lower efficacy (90% vs 95% clinical cure for nitrofurantoin) for uncomplicated UTI, according to the IDSA and Praxis Medical Insights 1, 2

The Infectious Diseases Society of America recommends a 5-day course of Macrobid (nitrofurantoin monohydrate/macrocrystals) 100 mg orally twice daily for uncomplicated acute cystitis in adult women, which has comparable efficacy to trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days when local resistance is low 4

The American College of Physicians advises against using fluoroquinolones as first-line treatment for uncomplicated acute cystitis due to collateral damage and resistance concerns, and instead recommends reserving them for more invasive infections 4

The American Urological Association suggests that if local trimethoprim-sulfamethoxazole resistance is <20% and the patient has no contraindications, trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days is an equivalent alternative to Macrobid for uncomplicated acute cystitis 4

The American Urological Association (AUA) recommends treating acute cystitis with “as short a duration as reasonable, generally no longer than seven days.” 5

The AUA advises that nitrofurantoin may be used continuously at 50–100 mg once daily at bedtime for extended periods (months to years) when prophylaxis is indicated. 5
The AUA emphasizes that the length of prophylactic therapy should be individualized according to each patient’s recurrence pattern and tolerance of the medication. 5

For children ≥ 12 years, nitrofurantoin 100 mg twice daily for 7 days (or at least 3 days after a sterile urine specimen) is recommended. 6
For children < 12 years, nitrofurantoin 5–7 mg/kg/day divided into four doses for 7 days (or at least 3 days after a sterile urine specimen) is recommended. 6

Nitrofurantoin should not be used for perinephric abscesses or complicated urinary tract infections with structural abnormalities. 6